|Jmol-3D images||Image 1|
|Molar mass||299.29 g mol−1|
| (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Saxitoxin (STX) is the best-known paralytic shellﬁsh toxin (PST), although other related compounds have been reported, such as neosaxitoxin (NSTX), the 11-alpha and 11-beta-O-sulphates of saxitoxin and neosaxitoxin, and carbonyl-N-sulphate derivatives of saxitoxin and neosaxitoxin.
STX is a neurotoxin naturally produced by certain species of marine dinoflagellates (Alexandrium sp., Gymnodinium sp., Pyrodinium sp.) and cyanobacteria (Anabaena sp., some Aphanizomenon spp., Cylindrospermopsis sp., Lyngbya sp., Planktothrix sp.). Ingestion of saxitoxin (usually through shellfish contaminated by toxic algal blooms) is responsible for the human illness known as paralytic shellfish poisoning (PSP).
In fact, the term saxitoxin originates from the species name of the butter clam (Saxidomus giganteus) in which it was first recognized. But, the term saxitoxin can also refer to the entire suite of related neurotoxins (known collectively as "saxitoxins") produced by these microorganisms, which include pure saxitoxin (STX), neosaxitoxin (NSTX), gonyautoxins (GTX) and decarbamoylsaxitoxin (dcSTX).
Detection of saxitoxin in shellfish such as mussels, clams and scallops frequently leads to closures of commercial and recreational shellfish harvesting, especially in California, Oregon, Washington, and New England.
STX has been found in at least 12 marine puffer fish fish species in Asia and one freshwater fish tilapia in Brazil. However, the ultimate source of STX is still uncertain. In the United States, paralytic shellfish poisoning is limited to New England and the West Coast. The dinoflagellate Pyrodinium bahamense is the source of STX found in Florida. Recent research shows the detection of STX in the skin, muscle, viscera, and gonads of “Indian River Lagoon” southern puffer fish, with the highest concentration (22,104 µg STX eq/100 g tissue) measured in the ovaries. Even after a year of captivity, the skin mucus remained highly toxic. The various concentrations in puffer fish from the United States are similar to those found in the Philippines, Thailand, Japan, and South American countries.
Saxitoxin is a neurotoxin that acts as a selective sodium channel blocker. One of the most potent natural toxins known to man, it acts on the voltage-gated sodium channels of nerve cells, preventing normal cellular function and leading to paralysis.
Although STX biosynthesis seems complex, organisms from the two kingdoms, species of marine dinoflagellates and freshwater cyanobacteria, are capable of making these toxins by the same biosynthetic pathway. The enzymes involved in the biosynthesis of STX have not been identified by previous studies.
Saxitoxin synthesis is the first non-terpene alkaloid pathway described for bacteria. A complete STX biosynthetic gene cluster (sxt) is used to obtain a more favourable reaction. The predicted reaction sequence of suggested SxtA, based on its primary structure, is the loading of the ACP with acetate from acetyl-CoA, followed by SxtA-catalyzed methylation of acetyl-ACP, which is then converted to propionyl-ACP. Later another SxtA performs a Claisen condensation reaction between propionyl-ACP and arginine producing 4.
SxtG transfers an amidino group from arginine to the α-amino 4 group producing 5, which later undergoes retroaldol-like condensation by SxtB. SxtD adds a double bond between C-1 and C-5 of 6, which gives rise to the 1,2-H shift between C-5 and C-6 in 7. SxtS performs an epoxidation of the double bond and opening of the epoxide to an aldehyde. SxtU reduces the terminal aldehyde group of the STX precursor 9 forming 10. SxtI catalyzes the transfer of a carbamoyl group to the free hydroxyl group on 10. SxtH and SxtT perform a similar function which is the consecutive hydroxylation of C-12 terminating the STX biosynthetic pathway. This is only a proposed biosynthetic pathway; the actual mechanism of how substrates bind to the enzymes is still unknown.
The challenge for chemical synthesis comes from the dense arrangement of heteroatoms on the tricyclic structure and the dicationic nature of STX further complicates the purification of the target molecule.
The starting material of this synthesis is a commercially available compound, a glycerol-derived sulfamate ester 12. This is oxidized to form a product N,O-acetal 13 and is alkynylated with zinc reagent and BF3•OEt2, producing 14 and a subsequent reaction of tosylation at the C10 of the substituted [1,2,3]-oxathiazinane-2,2-dioxide heterocycle, which later undergoes azide displacement of the primary tosylate 15. The p-methoxybenzyl (PMB) is used to protect the NH group by alkylation 16 before performing a reduction of azide with Me3P and a p-methoxybenzenesulfonyl (Mbs) containing compound to produce isothiourea 17. With the PMB and Mbs protecting groups, another azide is introduced at C6, losing PMB under oxidative condition 19. An imidoyl chloride, MbsN=CCl2, is used to re-protect the nitrogen near the tosylate site, before activating the oxathiazinane heterocycle by hydrolysis. At this point, 20, all the required carbon in tricyclic structure of STX is obtained. Next, Me3P is used to reduce azide which is then treated with AgNO3 resulting in carbodiimide formation and ring closure 23. Adding trichloroacetyl isocyanate, 23 is converted to carbamate derivative of STX 24 which can be easily isolated. The 4 double bonds on 24 are then oxidized which shows the efficiency of this synthetic route. An addition of another bicycle reagent of B(O2CCF3) in acid produces beta-STXol, while stabilizing the carbamate side chain. The last step of the synthesis is to oxidize on the carbon with hydroxyl group with DCC, DMSO, C5H5N•HO2CCF3. The product can be highly purified using CH3CN, H2O and 10 mM heptafluorobutyric acid, giving overall yield of 1.3%.
The human illness associated with ingestion of harmful levels of saxitoxin is known as paralytic shellfish poisoning, or PSP, and saxitoxin and its derivatives are often referred to as "PSP toxins".
The medical and ecological importance of saxitoxin lies mainly in effects of harmful algal blooms on shellfish and certain finfish which can concentrate the toxin, making it available both for human consumption as well as by various marine organisms. The blocking of neuronal sodium channels which occurs in PSP produces a flaccid paralysis that leaves its victim calm and conscious through the progression of symptoms. Death often occurs from respiratory failure. PSP toxins have been implicated in various marine animal mortalities involving trophic transfer of the toxin from its algal source up the food web to higher predators.
STX is highly toxic, killing guinea pigs at only 5 µg/kg when injected i.m. The lethal doses for mice are very similar with varying administration routes: t i.p. (LD50 = 10 µg/kg), i.v. (LD50 = 3.4 µg/kg) or p.o. (LD50 = 263 µg/kg). The oral LD50 for humans is 5.7 µg/kg, therefore approximately 0.57 mg of saxitoxin is lethal if ingested and the lethal dose by injection is about ten times lower (approximately 0.0000006 g). The human inhalation toxicity of aerosolized saxitoxin is estimated to be 5 mg·min/m³. Saxitoxin can enter the body via open wounds and a lethal dose of 0.05 mg/person by this route has been suggested. Saxitoxin is 1,000 times more toxic than the potent nerve gas sarin.
For a lung effect by aerosol, the median lethal dosage (LCt50) of TZ is 5 mg·min/m³. Due to its high aerobiological decay rate (e.g., ~17%/min) and production cost, it was weaponized in tainted flechettes for special operations.
Though its early isolation and characterization were from military efforts, saxitoxin has been more important to cellular research in delineating the function of the sodium channel.
- Action potential
- Alexandrium tamarense sp.
- Anabaena circinalis
- Harmful algal bloom
- Paralytic shellfish poisoning
- Blunden G. (2001). "Review: Biologically Active Compounds from Marine Organisms". Phytotherapy Research 15 (2): 89–94. doi:10.1002/ptr.982. PMID 11268103. Retrieved 2012-05-27.
- Clark R. F., Williams S. R., Nordt S. P., Manoguerra A. S. (1999). "A review of selected seafood poisonings". Undersea Hyperb Med 26 (3): 175–84. PMID 10485519. Retrieved 2008-08-12.
- Landsberg, Jan H. (2002). "The Effects of Harmful Algal Blooms on Aquatic Organisms". Reviews in Fisheries Science 10 (2): 113–390. doi:10.1080/20026491051695.
- Galvão, J. A.; Oetterer, M.; Bittencourt-Oliveira Mdo, M. D. C.; Gouvêa-Barros, S.; Hiller, S.; Erler, K.; Luckas, B.; Pinto, E. et al. (2009). "Saxitoxins accumulation by freshwater tilapia (Oreochromis niloticus) for human consumption". Toxicon 54 (6): 891–894. doi:10.1016/j.toxicon.2009.06.021. PMID 19560484.
- Smith, E. A.; Grant, F.; Ferguson, C. M. J.; Gallacher, S. (2001). "Biotransformations of Paralytic Shellfish Toxins by Bacteria Isolated from Bivalve Molluscs". Applied and Environmental Microbiology 67 (5): 2345–2353. doi:10.1128/AEM.67.5.2345-2353.2001. PMC 92876. PMID 11319121.
- Sato, S.; Kodama, M.; Ogata, T.; Saitanu, K.; Furuya, M.; Hirayama, K.; Kakinuma, K. (1997). "Saxitoxin as a toxic principle of a freshwater puffer, Tetraodon fangi, in Thailand". Toxicon 35 (1): 137–140. doi:10.1016/S0041-0101(96)00003-7. PMID 9028016.
- Landsberg, J. H.; Hall, S.; Johannessen, J. N.; White, K. D.; Conrad, S. M.; Abbott, J. P.; Flewelling, L. J.; Richardson, R. W.; Dickey, R. W.; Jester, Edward L.E.; Etheridge, Stacey M.; Deeds, Jonathan R.; Van Dolah, Frances M.; Leighfield, Tod A.; Zou, Yinglin; Beaudry, Clarke G.; Benner, Ronald A.; Rogers, Patricia L.; Scott, Paula S.; Kawabata, Kenji; Wolny, Jennifer L.; Steidinger, Karen A. (2006). "Saxitoxin Puffer Fish Poisoning in the United States, with the First Report of Pyrodinium bahamense as the Putative Toxin Source". Environmental Health Perspectives 114 (10): 1502–1507. doi:10.1289/ehp.8998. PMC 1626430. PMID 17035133.
- Deeds, J. R.; Landsberg, J. H.; Etheridge, S. M.; Pitcher, G. C.; Longan, S. W. (2008). "Non-Traditional Vectors for Paralytic Shellfish Poisoning". Marine Drugs 6 (2): 308–348. doi:10.3390/md6020308. PMC 2525492. PMID 18728730.
- Lagos, N. S.; Onodera, H.; Zagatto, P. A.; Andrinolo, D. ́O.; Azevedo, S. M. F. Q.; Oshima, Y. (1999). "The first evidence of paralytic shellfish toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii, isolated from Brazil". Toxicon 37 (10): 1359–1373. doi:10.1016/S0041-0101(99)00080-X. PMID 10414862.
- Huot, R. I.; Armstrong, D. L.; Chanh, T. C. (June 1989). "Protection against nerve toxicity by monoclonal antibodies to the sodium channel blocker tetrodotoxin". Journal of Clinical Investigation 83 (6): 1821–1826. doi:10.1172/JCI114087. PMC 303901. PMID 2542373.
- Shimizu, Yuzuru (June 2003). "Microalgal metabolites". Current Opinion in Microbiology 6 (3): 236–243. doi:10.1016/S1369-5274(03)00064-X. PMID 12831899.
- Pomati, F.; Burns, B. P.; Neilan, B. A. (2004). "Identification of an Na(+)-Dependent Transporter Associated with Saxitoxin-Producing Strains of the Cyanobacterium Anabaena circinalis". Applied and Environmental Microbiology 70 (8): 4711–4719. doi:10.1128/AEM.70.8.4711-4719.2004. PMC 492425. PMID 15294806.
- Shimizu, Y.; Norte, M.; Hori, A.; Genenah, A.; Kobayashi, M. (1984). "Biosynthesis of saxitoxin analogs: The unexpected pathway". Journal of the American Chemical Society 106 (21): 6433–6434. doi:10.1021/ja00333a062.
- Kellmann, R.; Mihali, T. K.; Jeon, Y. J.; Pickford, R.; Pomati, F.; Neilan, B. A. (2008). "Biosynthetic Intermediate Analysis and Functional Homology Reveal a Saxitoxin Gene Cluster in Cyanobacteria". Applied and Environmental Microbiology 74 (13): 4044–4053. doi:10.1128/AEM.00353-08. PMC 2446512. PMID 18487408.
- Fleming, James J.; McReynolds, Matthew D.; Du Bois, J. (2007). "(+)-Saxitoxin: A First and Second Generation Stereoselective Synthesis". Journal of the American Chemical Society 129 (32): 9964–9975. doi:10.1021/ja071501o. PMID 17658800.
- Benton, B. J.; Keller, S. A.; Spriggs, D. L.; Capacio, B. R.; Chang, F. C. (1998). "Recovery from the lethal effects of saxitoxin: A therapeutic window for 4-aminopyridine (4-AP)". Toxicon : official journal of the International Society on Toxinology 36 (4): 571–588. PMID 9643470.
- Chang, F. C.; Spriggs, D. L.; Benton, B. J.; Keller, S. A.; Capacio, B. R. (1997). "4-Aminopyridine reverses saxitoxin (STX)- and tetrodotoxin (TTX)-induced cardiorespiratory depression in chronically instrumented guinea pigs". Fundamental and applied toxicology : official journal of the Society of Toxicology 38 (1): 75–88. doi:10.1006/faat.1997.2328. PMID 9268607.
- Chen, H.; Lin, C.; Wang, T. (1996). "Effects of 4-Aminopyridine on Saxitoxin Intoxication". Toxicology and Applied Pharmacology 141 (1): 44–48. doi:10.1006/taap.1996.0258. PMID 8917674.
- Patocka J; Stredav L (April 23, 2002). "Brief Review of Natural Nonprotein Neurotoxins". In Price, Richard. ASA Newsletter (Applied Science and Analysis inc.) 02–2 (89): 16–23. ISSN 1057-9419. Retrieved 26 May 2012.
- Unauthorized Storage of Toxic Agents. Church Committee Reports 1. The Assassination Archives and Research Center (AARC). 1975–1976. p. 7.
-  Paralytic Shellfish Poisoning
-  Neil Edwards. The Chemical Laboratories. School of Chemistry, Physics & Environmental Science. University of Sussex at Brighton. Saxitoxin - from food poisoning to chemical warfare
- Toxic cyanobacteria in water: A guide to their public health consequences, monitoring and management. Edited by Ingrid Chorus and Jamie Bartram, 1999. Published by World Health Organization. ISBN 0-419-23930-8 (English)